AnaptysBio adopts amended bylaws to align with DGCL changes and universal proxy rules

ANAPTYSBIO, INC

Board approved Second Amended and Restated Bylaws effective Feb 7, 2023; updates advance notice, proxy procedures, and exclusive forum clause.
Amendments conform to 2022 DGCL changes on adjournment, stockholder lists, and electronic notices; adds emergency bylaw provision.
Enhanced stockholder nomination requirements: limits nominees to board seats, mandates compliance with SEC Universal Proxy Rules (Rule 14a-19).
Exclusive forum clause designates federal district courts for Securities Act claims unless company consents otherwise.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

ANAPTYSBIO, INC: Adoption of second amended and restated bylaws with changes related to universal proxy rules, DGCL amendments, advance notice provisions, emergency bylaws, and exclusive forum for Securities Act claims (effective 2023-02-07).

Change: bylaw amendment
Effective: 2023-02-07

Exact text from the filing

approved and adopted the Company’s second amended and restated bylaws

View on SEC.gov

188 governance changes filed in the last 30 days. Browse all governance changes →

ANAPTYSBIO, INC filing history →

Source: SEC EDGAR

accession 0001370053-23-000013

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.